Jiaheng Qiu

Jiaheng Qiu

Genentech, Inc - South San Francisco / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4380862
-
person_outline Jiaheng Qiu's MOST POPULAR ARTICLES
1-) Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinomaDF McDermott, MA Huseni, MB Atkins, RJ Motzer, BI Rini, B Escudier, ...Nature medicine 24 (6), 749-757, 201810902018
2-) Phase II trial of atezolizumab as first-line or subsequent therapy for patients with programmed death-ligand 1–selected advanced non–small-cell lung cancer (BIRCH)S Peters, S Gettinger, ML Johnson, PA Jänne, MC Garassino, D Christoph, ...Journal of Clinical Oncology 35 (24), 2781-2789, 20174092017
3-) Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 …IE Krop, IA Mayer, V Ganju, M Dickler, S Johnston, S Morales, DA Yardley, ...The lancet oncology 17 (6), 811-821, 20163112016
4-) Diabetes and the risk of developing Parkinson’s disease in DenmarkE Schernhammer, J Hansen, K Rugbjerg, L Wermuth, B RitzDiabetes care 34 (5), 1102-1108, 20112302011
5-) Treatment for Helicobacter pylori infection and risk of parkinson’s disease in DenmarkHH Nielsen, J Qiu, S Friis, L Wermuth, B RitzEuropean journal of neurology 19 (6), 864-869, 20121912012